Alison Jane Eastwood

Search results

• 2024

  Iptacopan for treating paroxysmal nocturnal haemoglobinuria: A Single Technology Appraisal

  Rodgers, M., Kunst, N., Umemneku-Chikere, C., Zhou, A., Gao, M., Fulbright, H. A., Eastwood, A. J. & Rothery, C., 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2023

  Ciltacabtagene autoleucel for treating relapsed or refractory multiple myeloma

  Llewellyn, A., Murphy, P. J., Beresford, L., Walton, M. J., Fulbright, H. A., Harden, M., Eastwood, A. J. & Hodgson, R., 17 May 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Cipaglucosidase alfa with miglustat for treating Pompe disease

  Wade, R., Deng, J., Dwan, K., Robertson, L., Uphoff, N., Fulbright, H. A., Dias, S., Hodgson, R. & Eastwood, A. J., 15 Aug 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Dupilumab for treating prurigo nodularis: External Assessment Group Report for the National Institute for Health and Care Excellence

  Corbett, M. S., Zhou, A., Anwer, S., Wade, R., Chen, T., Fulbright, H. A., Bojke, L., Eastwood, A. J. & Rothery, C., Aug 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer (Rapid Review of TA885)

  Walton, M. J., Rodgers, M., Fulbright, H. A., Eastwood, A. J. & Hodgson, R., 13 Dec 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer [ID3798]Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer

  Rodgers, M., Walton, M. J., Anwer, S., Corbett, M. S., Njoroge, M. W., Fulbright, H. A., Naik, R., Powell, M., Eastwood, A. J. & Hodgson, R., 29 Mar 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2021

  Avatrombopag in combination for treating chronic immune thrombocytopenia. Evidence Review Group Report for the National Institute for Health and Care Excellence.

  Cox, E. M., Corbett, M. S., Saramago Goncalves, P., Melton, H. A., Harden, M., Walker, S. M., Dias, S., Rothery, C. & Eastwood, A. J., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Cenobamate for adjunctive treatment of focal epilepsy: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Jankovic, D., Llewellyn, A., Anwer, S., Harden, M., Faria, R., Rothery, C., Eastwood, A. J. & Saramago Goncalves, P. R., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Ravulizumab for atypical Haemolytic Uremic Syndrome: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Nikolaidis, G., Llewellyn, A., Schmitt, L. H. M., Meader, N., Walker, S. M., Harden, M., Rothery, C. & Eastwood, A. J., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2020

  KTE-X19 for treating relapsed or refractory mantle cell lymphoma: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Nikolaidis, G., Murphy, P. J., Jankovic, D., Llewellyn, A., Palmer, S. J., Wright, K., Eastwood, A. J. & Faria, R., 2020, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2019

  Certolizumab pegol for treating moderate to severe plaque psoriasis

  Walton, M. J., Sharif, S., Claxton, L., Wade, R., Hodgson, R., Harden, M. & Eastwood, A. J., 17 Apr 2019, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2018

  Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma, mediastinal B-cell lymphoma and follicular lymphoma. Single Technology Appraisal Evidence Assessment Group report

  Corbett, M. S., Duarte, A. I., Melton, H. A., Walker, S. M., Wright, K., Eastwood, A. J. & Palmer, S. J., 2018, 674 p.

  Research output: Book/Report › Commissioned report

  Open Access
• 2015

  Evidence Review Group's Report: Vortioxetine for treating major depressive disorder. Report to NICE.

  Simmonds, M. C., Lomas, J. R. S., Llewellyn, A. R., Soares, M. F. O., Wright, K., Eastwood, A. J. & Palmer, S. J., 2015, NICE. 151 p.

  Research output: Book/Report › Commissioned report
• 2014

  Service user engagement and health service reconfiguration

  Dalton, J. E., Chambers, D., Harden, M., Street, A. D., Parker, G. M. & Eastwood, A. J., Sept 2014, Centre for Reviews and Dissemination/ Centre for Health Economics. 132 p.

  Research output: Book/Report › Commissioned report
• 2013

  Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal.

  Duarte, A. I., Burch, J. A., Smith, A., Walker, S. M., Fox, D., Rodriguez-Lopez, R., Palmer, S. J. & Eastwood, A. J., 2013, NICE.

  Research output: Book/Report › Commissioned report

• Ipilimumab for previously untreated unresectable malignant melanoma. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Wade, R., Giannopoulou, C. D., Sideris, E., Moe-Byrne, T., Harden, M., Rothery, C. & Eastwood, A. J., 2013, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2011

  Fingolimod for the treatment of relapsing remitting multiple sclerosis

  CRD and CHE Technology Assessment Group, Asaria, M., Norman, G., Hinde, S., O'Connor, J., Palmer, S. J., Light, K., O Soares, M. & Eastwood, A. J., Jun 2011, Centre for Reviews and Dissemination/ Centre for Health Economics.

  Research output: Book/Report › Commissioned report

• 2010

  Capecitabine for the treatment of advanced gastric cancer.

  Norman, G., Soares, M. O., Peura, P., Rice, S. J., Suh, D., Wright, D., Sculpher, M. & Eastwood, A. J., 2010, National Institute for Health and Clinical Excellence.

  Research output: Book/Report › Commissioned report

• Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

  CRD and CHE Technology Assessment Group, Norman, G., Rice, S. J., Spackman, E., Stirk, L., Danso-Appiah, T., Suh, D., Palmer, S. J. & Eastwood, A. J., May 2010, Centre for Reviews and Dissemination/ Centre for Health Economics.

  Research output: Book/Report › Commissioned report
• 2009

  Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix

  CRD and CHE Technology Assessment Group, Paton, F. C. W., Paulden, M., Saramago, P., Manca, A., Misso, K., Palmer, S. J. & Eastwood, A. J., Apr 2009, Centre for Reviews and Dissemination/ Centre for Health Economics.

  Research output: Book/Report › Commissioned report
• 2007

  Psychosocial interventions for non-professional carers of people with Parkinson's Disease: a scoping review.

  Hempel, S., Norman, G., Golder, S., Aguiar-Ibáñez, R. & Eastwood, A., Dec 2007, York: University of York. 96 p.

  Research output: Book/Report › Commissioned report
• 2006

  Parenteral oestrogens for prostate cancer: a systematic review of clinical effectiveness and dose response

  Emmans Dean, M., Norman, G., Hodges, Z., Eastwood, A., Langley, R., Sydes, M., Parmar, M., Abel, P., Ritchie, G. & Light, K., Sept 2006, York: University of York. 108 p.

  Research output: Book/Report › Commissioned report

• Systematic review of barriers, modifiers and benefits involved in participation in cancer clinical trials

  Fayter, D., McDaid, C., Eastwood, A., Ritchie, G. & Stirk, L., Mar 2006, York, UK: University of York. 157 p. (CRD Report)

  Research output: Book/Report › Commissioned report

• Systematic review of interventions to increase participation of cancer patients in randomised controlled trials

  McDaid, C., Fayter, D., Eastwood, A., Hodges, Z. & Stirk, L., Mar 2006, York, UK: University of York. 64 p. (CRD Report)

  Research output: Book/Report › Commissioned report
• 2005

  A systematic review of cancer waiting time audits

  Collins, R., Dean, M. E., Wilson, P., Eastwood, A., Lewis, R., Flynn, A. & Myers, L., Feb 2005, York, UK: University of York. 127 p. (CRD Report)

  Research output: Book/Report › Commissioned report